Cargando…
Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment
OBJECTIVE: To prepare technetium-99m ((99m)Tc)-labeled pH (low) insertion peptide variant 7 [pHLIP (Var7)] and carry out small-animal single-photon-emission computed tomography (SPECT)/computed tomography (CT) imaging of tumor-bearing nude mice in vivo to study its value in the early diagnosis of tr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069674/ https://www.ncbi.nlm.nih.gov/pubmed/35530359 http://dx.doi.org/10.3389/fonc.2022.869260 |
_version_ | 1784700480774995968 |
---|---|
author | Chen, Yuehua Su, Yuan Pang, Xufeng Song, Xiaoxia Zhao, Wanjun Yu, Mingming |
author_facet | Chen, Yuehua Su, Yuan Pang, Xufeng Song, Xiaoxia Zhao, Wanjun Yu, Mingming |
author_sort | Chen, Yuehua |
collection | PubMed |
description | OBJECTIVE: To prepare technetium-99m ((99m)Tc)-labeled pH (low) insertion peptide variant 7 [pHLIP (Var7)] and carry out small-animal single-photon-emission computed tomography (SPECT)/computed tomography (CT) imaging of tumor-bearing nude mice in vivo to study its value in the early diagnosis of triple-negative breast cancer (TNBC). METHODS: The pHLIP (Var7) sequence was synthesized via solid-phase peptide synthesis. Four amino acids, Gly-(D)-Ala-Gly-Gly, were attached to the N-terminus of pHLIP (Var7) to form a strong chelating group containing an N4 structure. The peptide was labeled with (99m)Tc using a direct labeling method. We determined the in vitro binding fraction of (99m)Tc-pHLIP (Var7) to MDA-MB-231 cells. Serial biodistribution studies and small-animal SPECT/CT imaging in MDA-MB-231 TNBC-bearing mice were performed using (99m)Tc-pHLIP (Var7). RESULTS: The radiochemical yield and purity of (99m)Tc-pHLIP (Var7) were 99.49 ± 0.17% and 99.63 ± 0.44%, respectively. The radiochemical purity was still more than 96% after 24 h in serum. The binding fraction of (99m)Tc-pHLIP (Var7) to MDA-MB-231 cells continuously increased in an acidic environment and was significantly higher than the cell-binding fraction (P < 0.01) at pH = 7.4 and the cell-binding fraction (P < 0.01) of (99m)Tc-kVar7 at different pH values (pH = 6.0, 6.5, 7.0 and 7.4) at each time point (P < 0.01). The distribution of (99m)Tc-pHLIP (Var7) in tumors at each time point was significantly greater than that of (99m)Tc-kVar7 (P < 0.01). SPECT/CT imaging was largely consistent with the biodistribution results; the tumor was clearly imaged at each time point after injection of (99m)Tc-pHLIP (Var7) but could not be imaged after injection of (99m)Tc-kVar7. CONCLUSION: (99m)Tc-pHLIP (Var7) showed a high radiochemical yield and stability and was highly concentrated in tumor tissues. Although there was strong radioactive background in the abdomen of tumor-bearing nude mice, it did not hinder early diagnosis of TNBC. |
format | Online Article Text |
id | pubmed-9069674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90696742022-05-05 Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment Chen, Yuehua Su, Yuan Pang, Xufeng Song, Xiaoxia Zhao, Wanjun Yu, Mingming Front Oncol Oncology OBJECTIVE: To prepare technetium-99m ((99m)Tc)-labeled pH (low) insertion peptide variant 7 [pHLIP (Var7)] and carry out small-animal single-photon-emission computed tomography (SPECT)/computed tomography (CT) imaging of tumor-bearing nude mice in vivo to study its value in the early diagnosis of triple-negative breast cancer (TNBC). METHODS: The pHLIP (Var7) sequence was synthesized via solid-phase peptide synthesis. Four amino acids, Gly-(D)-Ala-Gly-Gly, were attached to the N-terminus of pHLIP (Var7) to form a strong chelating group containing an N4 structure. The peptide was labeled with (99m)Tc using a direct labeling method. We determined the in vitro binding fraction of (99m)Tc-pHLIP (Var7) to MDA-MB-231 cells. Serial biodistribution studies and small-animal SPECT/CT imaging in MDA-MB-231 TNBC-bearing mice were performed using (99m)Tc-pHLIP (Var7). RESULTS: The radiochemical yield and purity of (99m)Tc-pHLIP (Var7) were 99.49 ± 0.17% and 99.63 ± 0.44%, respectively. The radiochemical purity was still more than 96% after 24 h in serum. The binding fraction of (99m)Tc-pHLIP (Var7) to MDA-MB-231 cells continuously increased in an acidic environment and was significantly higher than the cell-binding fraction (P < 0.01) at pH = 7.4 and the cell-binding fraction (P < 0.01) of (99m)Tc-kVar7 at different pH values (pH = 6.0, 6.5, 7.0 and 7.4) at each time point (P < 0.01). The distribution of (99m)Tc-pHLIP (Var7) in tumors at each time point was significantly greater than that of (99m)Tc-kVar7 (P < 0.01). SPECT/CT imaging was largely consistent with the biodistribution results; the tumor was clearly imaged at each time point after injection of (99m)Tc-pHLIP (Var7) but could not be imaged after injection of (99m)Tc-kVar7. CONCLUSION: (99m)Tc-pHLIP (Var7) showed a high radiochemical yield and stability and was highly concentrated in tumor tissues. Although there was strong radioactive background in the abdomen of tumor-bearing nude mice, it did not hinder early diagnosis of TNBC. Frontiers Media S.A. 2022-04-21 /pmc/articles/PMC9069674/ /pubmed/35530359 http://dx.doi.org/10.3389/fonc.2022.869260 Text en Copyright © 2022 Chen, Su, Pang, Song, Zhao and Yu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Chen, Yuehua Su, Yuan Pang, Xufeng Song, Xiaoxia Zhao, Wanjun Yu, Mingming Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment |
title | Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment |
title_full | Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment |
title_fullStr | Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment |
title_full_unstemmed | Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment |
title_short | Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment |
title_sort | synthesis and evaluation of technetium-99m-labeled ph (low) insertion peptide variant 7 for early diagnosis of mda-mb-231 triple-negative breast cancer by targeting the tumor microenvironment |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069674/ https://www.ncbi.nlm.nih.gov/pubmed/35530359 http://dx.doi.org/10.3389/fonc.2022.869260 |
work_keys_str_mv | AT chenyuehua synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment AT suyuan synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment AT pangxufeng synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment AT songxiaoxia synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment AT zhaowanjun synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment AT yumingming synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment |